1. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis;Acharya;J Assoc Physicians India,1995
2. An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis;Agarwal;J Intern Med,2006
3. Barril, G., Montenegro, J., Ronco, C. et al. (2005). Aranesp (darbepoetin alfa) administered every 2 weeks (Q2W) effectively maintains haemoglobin in patients receiving peritoneal dialysis: results of a pooled analysis of eight European studies. Paper presented at 42nd ERA-EDTA Congress, Istanbul, Turkey.
4. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin;Besarab;N Engl J Med,1998
5. Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients;Besarab;Am J Kidney Dis,2002